Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 6.25
  • 52 Week Low: 3.50
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,494,153
  • Market Cap: £20.80m

Eden Research Overview

Eden Research is in the pharma and biotech sector and is currently trading at 3.90p per share. In the last year Eden Research's share price has ranged from 3.50p to 6.25p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -58.5% -48.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.5 4.7
Pr/Book 1.5  
Latest F'cast
Revenue 74.7% 34.7%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Eden Research Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 2.05 (1.48) (0.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 1.37 (2.55) (0.66)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.23 (3.40) (0.73)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.83 (2.57) (0.59)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.19 (6.92) (1.54)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Eden Research Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 4.30 (2.10) (0.30)p n/a n/a n/a n/a 0.0%
31-Dec-25 5.00 (1.80) (0.30)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Eden Research Company Announcements

Trading Update 07-Nov-2024 07:01 RNS
Ecovelex Approval in Italy 07-Nov-2024 07:00 RNS
OTCQB exchange update 08-Oct-2024 11:24 RNS

Eden Research ShareCast News

Eden Research product granted temporary approval... 02-Sep-2024 ShareCast
Eden Research revenue set to beat market expecta... 22-Jan-2024 ShareCast
Eden Research bird repellant gets temporary appr... 18-Dec-2023 ShareCast

Latest Eden Research Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.90p
Change Today 0.100p
% Change 2.63 %
52 Week High 6.25
52 Week Low 3.50
Volume 1,494,153
Shares Issued 533.35m
Market Cap £20.80m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.24% below the market average13.24% below the market average13.24% below the market average13.24% below the market average13.24% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
49.88% below the market average49.88% below the market average49.88% below the market average49.88% below the market average49.88% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Income Not Available
Growth
53.16% above the market average53.16% above the market average53.16% above the market average53.16% above the market average53.16% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Eden Research Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:54 137,044 @ 3.89p
15:54 146,222 @ 3.89p
15:39 240,000 @ 3.90p
13:26 130,000 @ 3.90p
13:26 150,000 @ 3.85p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page